4.8 Editorial Material

Opportunities and challenges using artificial intelligence in ADME/Tox

Journal

NATURE MATERIALS
Volume 18, Issue 5, Pages 418-422

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41563-019-0332-5

Keywords

-

Funding

  1. NCATS NIH HHS [R44 TR000942] Funding Source: Medline
  2. NIGMS NIH HHS [R44 GM122196] Funding Source: Medline
  3. NIH HHS [R44 GM122196-02A1] Funding Source: Medline

Ask authors/readers for more resources

At the recent Artificial Intelligence Applications in Biopharma Summit in Boston, USA, a panel of scientists from industry who work at the interface of machine learning and pharma discussed the diverging opinions on the past, present and future role of AI for ADME/Tox in drug discovery and development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available